Cost-effectiveness of reduction mammaplasty

Taylor, Andrew J.; Tate, David F.; Brandberg, Yvonne; Blomqvist, Lennart

doi:10.1017/s0266462304001072

Cited by 17 publications

(15 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…23 In another study, the SF-6D was applied to calculate utility for women with breast hypertrophy; however, it showed only the cost per QALY-not the utility value. 5 The Health-Related Quality of Life (HRQoL) instrument was utilized in a Finnish study and demonstrated a utility value of 0.91 before surgery and 0.93 six months after surgery. 10 In our study, the initial preoperative utility value was 0.63.…”

Section: Discussionmentioning

confidence: 99%

“…5 The cost per QALY was estimated to range from £4733 to £5729. In Finland, the direct average cost of hospital treatment, including outpatient visits, was approximately £2798, whereas the cost per QALY was £3009.…”

Section: Discussionmentioning

confidence: 99%

“…[1][2][3][4] Although reduction mammaplasty improves these problems, the procedure is still considered merely cosmetic by many women who require it, by many providers, and even by some medical professionals. 5 Policies that regulate public health assistance pose challenges for many countries, including Brazil, which is facing a crisis because of accumulating health care utilization costs. 6 Because economic resources are limited, economic evaluations have become an important part of the decisionmaking process surrounding the distribution of funds, with the goal of utilizing resources as efficiently and effectively as possible.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Cost-Utility of Reduction Mammaplasty Assessed for the Brazilian Public Health System

Araújo

Veiga²,

Hochman

et al. 2014

Aesthetic Surgery Journal

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Cost-Utility of Reduction Mammaplasty Assessed for the Brazilian Public Health System

Araújo

Veiga²,

Hochman

et al. 2014

Aesthetic Surgery Journal

View full text Add to dashboard Cite

show abstract

“…Breast reduction surgery is a common plastic surgery procedure and it has previously been shown to be effective for relieving pain and functional problems associated with breast hypertrophy,1–5 whereas conservative approaches to treatment such as physiotherapy, hormonal therapy and weight loss have much less impact 6 7. However, despite clear published evidence to the contrary, breast reduction surgery is often regarded more as a cosmetic rather than a functional procedure by the general public and many medical professionals 1 8 9. This is in spite of the finding that breast hypertrophy is a chronic health problem and relief of physical symptoms is the primary motivator for most women who are pursuing breast reduction surgery 10…”

Section: Introductionmentioning

confidence: 99%

Does breast reduction surgery improve health-related quality of life? A prospective cohort study in Australian women

et al. 2020

View full text Add to dashboard Cite

Strengths and limitations of this study► This large prospective longitudinal study reports 12-month follow-up using a validated patientreported outcome measure for health-related quality of life assessment. ► The completion rate of the study was 83% for participants who underwent surgery. ► Comparisons were made with a control cohort of women with breast hypertrophy not undergoing surgery, and also to a normative female reference population. ► This was a non-randomised study design. AbStrACtObjectives To assess the health burden of breast hypertrophy and the comparative effectiveness of breast reduction surgery in improving health-related quality of life.Design Prospective cohort study. Setting A major public tertiary care hospital in Australia. Participants Women with symptomatic breast hypertrophy who underwent breast reduction surgery were followed for 12 months. A comparison control cohort comprised women with breast hypertrophy who did not undergo surgery.Interventions Bilateral breast reduction surgery for women in the surgical cohort. Main outcome measures The primary outcome measure was health-related quality of life measured preoperatively and at 3, 6 and 12 months postoperatively using the Short Form-36 (SF-36) questionnaire. Secondary outcome measures included post-surgical complications. results 209 patients in the surgical cohort completed questionnaires before and after surgery. 124 patients in the control hypertrophy cohort completed baseline and 12-month follow-up questionnaires. At baseline, both groups had significantly lower scores compared with population norms across all scales (p<0.001). In the surgical cohort significant improvements were seen across all eight SF-36 scales (p<0.001) following surgery. Within 3 months of surgery scores were equivalent to those of the normal population and this improvement was sustained at 12 months. SF-36 physical and mental component scores both significantly improved following surgery, with a mean change of 10.2 and 9.2 points, respectively (p<0.001). In contrast, SF-36 scores for breast hypertrophy controls remained at baseline across 12 months. The improvement in quality of life was independent of breast resection weight and body mass index. Conclusion Breast reduction significantly improved quality of life in women with breast hypertrophy. This increase was most pronounced within 3 months of surgery and sustained at 12-month follow-up. This improvement in quality of life is comparable to other widely accepted surgical procedures. Furthermore, women benefit from surgery regardless of factors including body mass index and resection weight.

show abstract

“…In these studies, the effectiveness can be assessed through quality of live instruments 7 . Cost- effectiveness also allows checking which strategy is more effective 8 …”

Section: Introductionmentioning

confidence: 99%

Health economics and health preference concepts to orthopedics practitioners

et al. 2014

View full text Add to dashboard Cite

The aim of this study was to describe concepts of health economics in order to update and provide the orthopedic practitioner decision making parameters based on preferences. Four basic types of studies of economical evaluation were presented (cost minimization analysis, cost-benefit, cost-effectiveness and cost-utility), as well as the origin, the concept, advantages and disadvantages of using QALY and utility. It was discussed the importance of costs and of SF-6D, an instrument able to get through the utility data from the Medical Outcomes Study 36-item Short Form Health Survey (SF-36). Physicians, especially orthopedic practitioners, are increasingly using technologies which are progressively expensive, thus, they should be able to understand health economics concepts, the importance of utility in clinical decision making process and economic analysis in health.09+

show abstract

Cost-effectiveness of reduction mammaplasty

Abstract: The authors suggest that the evidence in favor of funding reduction mammaplasty is strong and that decision-makers review their policy in light of this new evidence.

Cited by 17 publications

References 16 publications

Cost-Utility of Reduction Mammaplasty Assessed for the Brazilian Public Health System

Cost-Utility of Reduction Mammaplasty Assessed for the Brazilian Public Health System

Does breast reduction surgery improve health-related quality of life? A prospective cohort study in Australian women

Health economics and health preference concepts to orthopedics practitioners

Contact Info

Product

Resources

About